Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension
Clinical trial NCT02951429 · COMPLETED
Trial details
- NCT number
- NCT02951429
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-31
- Primary completion
- 2019-09-26
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.